Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shinobu Kimura is active.

Publication


Featured researches published by Shinobu Kimura.


Journal of Hypertension | 1990

FUNCTIONAL RELATIONSHIPS BETWEEN PLATELET ALPHA2-ADRENOCEPTORS AND SYMPATHETIC NERVE ACTIVITY IN CLINICAL HYPERTENSIVE STATES

Takao Noshiro; Yukio Miura; Shinobu Kimura; Yuki Meguro; Takashi Sugawara; Hirofumi Ohashi; Masaki Takahashi; Naoki Sano; Hiroshi Watanabe; Takashi Ohzeki; Kazumasa Shimizu; Kaoru Yoshinaga

Tritiated yohimbine binding was used to estimate platelet membrane alpha 2-adrenoceptor characteristics in normal subjects (n = 12) and patients with essential hypertension (n = 30), primary hyperaldosteronism (n = 10) and phaeochromocytoma (n = 10). There was a 20-fold increase in mean levels of resting norepinephrine and epinephrine in the phaeochromocytoma group. Total binding sites (Bmax) and dissociation constant (Kd) for 3H-yohimbine did not differ significantly among the four groups. Following curative surgery for phaeochromocytoma, plasma catecholamine levels were normalized but the Bmax remained unchanged. Following surgery for primary hyperaldosteronism, levels of plasma norepinephrine rose but Bmax was not changed. In all but the phaeochromocytoma patients, Bmax values correlated positively (r = 0.437, n = 48, P less than 0.01) with resting plasma norepinephrine. A significant negative correlation was observed between the change in plasma norepinephrine in response to postural change and resting Bmax. Treatment for 2-4 weeks with guanabenz or bethanidine induced a parallel fall in both Bmax and plasma norepinephrine. Treatment with reserpine was followed by a comparable fall in plasma norepinephrine, but Bmax values were unchanged. The findings support the view that platelet alpha 2-adrenoceptor density is functionally regulated in parallel with sympathetic nerve activity rather than circulating catecholamine levels, although it is not known which neuronal substance(s) may participate in this regulation.


Clinical and Experimental Pharmacology and Physiology | 1989

A sympathetic component of baroreflex function in patients with essential hypertension.

Yuki Meguro; Yukio Miura; Shinobu Kimura; Takao Noshiro; Takashi Sugawara; Masaki Takahashi; Hiroshi Watanabe; Naoki Sano; Takashi Ohzeki; Kazumasa Shimizu; Kaoru Yoshinaga

1 The baroreflex‐mediated changes in plasma norepinephrine (NE) and heart period (RR interval) to phenylephrine (PE)‐evoked pressor and nitroprusside (NP)‐evoked depressor stimulations were studied in 19 patients with chronic essential hypertension, 12 with borderline hypertension and in 11 age‐matched normal controls. 2 Intravenous infusion of PE at a rate of 0.25‐1.0 |ig/kg/min induced dose‐related increases in fhean arterial pressure (MAP) and in RR interval and a decrease in plasma NE. Similarly, NP infusion at a rate of 0.1‐0.4 ug/kg/min evoked the opposite changes in each variable. The reflex sensitivity was defined as the slope of linear regression between the changes in RR interval and MAP (RR/MAP) and between those in plasma NE (% of the baselines) and MAP (%NE/MAP). 3 Both RR/MAP and %NE/MAP for pressor and depressor stimulations were reduced below values found in normal subjects, in both chronic and borderline hypertensives. 4 The values of %NE/MAP was negatively related to the basal plasma NE during falls in blood pressure (r= ‐0.401, P<0.05). 5 The %NE/MAP may be a useful index of the sympathetic component of baro‐reflex sensitivity. A decrease in %NE/MAP in hypertensive and borderline hypertensive patients suggests a blunted sensitivity of the sympathetic constrictor reflexes.


Clinical and Experimental Hypertension | 1989

Functional Relationship Between Platelet α2-Adrenoceptors and Sympathetic Nerve Activity in Man

Takao Noshiro; Yukio Miura; Shinobu Kimura; Yuki Meguro; Takashi Sugawara; Hirofumi Ohashi; Masaki Takahashi; Naoki Sano; Hiroshi Watanabe; Takashi Ohzeki; Kazumasa Shimizu; Kaoru Yoshinaga

Functional relationships between platelet α2-adrenoceptors and sympathetic nerve activity were studied in patients with essential hypertension (n=23), primary aldosteronism (n=10), and normal subjects (n=12). The maximum number of binding sites (Bmax) and the dissociation constant (Kd) of 3H-yohimbine on platelet membranes and resting plasma norepinephrine (NE) were similar among these groups of subjects. In all subjects combined, Bmax values were correlated positively (r=0.471, p<0.01) to resting plasma NE and negatively (r=-0.531, p<0.01) to the changes in plasma NE when subjects were moved from lying to standing. A 2–4 week treatment with guanabenz or bethanidine induced a parallel fall of both Bmax and plasma NE, whereas administration of reserpine caused a similar fall of plasma NE but Bmax remained unchanged. Kd values were not changed after any of these treatments.The results support the view that platelet α2-adrenoceptor density is functionally regulated in parallel with sympathetic nerve activity...


The Journal of Clinical Endocrinology and Metabolism | 1990

Immunoreactive Corticotropin-Releasing Hormone, Growth Hormone-Releasing Hormone, Somatostatin, and Peptide Histidine Methionine Are Present in Adrenal Pheochromocytomas, but not in Extra-adrenal Pheochromocytoma*

Atsushi Sasaki; Shigeru Yumita; Shinobu Kimura; Yukio Miura; Kaoru Yoshinaga


Japanese Circulation Journal-english Edition | 1983

The effect of sodium depletion on plasma norepinephrine kinetics in patients with essential hypertension.

Shinobu Kimura; Yukio Miura; Maki Adachi; Michiko Adacha; Mitsuhiro Nezu; Shunichi Toriyabe; Takashi Sugawara; Yuki Ishizuka; Takao Noshiro; Masaki Takahashi; Hirofumi Ohashi; Kaoru Yoshinaga


Japanese Circulation Journal-english Edition | 1987

The baroreflex-mediated changes in plasma norepinephrine and heart rate in patients with essential hypertension.

Yuki Ishzuka; Yukio Miura; Shinobu Kimura; Hirobumi Ohashi; Takashi Sugawara; Hiroshi Watanabe; Takao Noshiro; Masaki Takahashi; Naoki Sano; Kaoru Yoshinaga


Japanese Circulation Journal-english Edition | 1983

The role of epinephrine in essential hypertension.

Mitsuhiro Nezu; Yukio Miura; Maki Adachi; Michiko Adachi; Shinobu Kimura; Shunichi Toriyabe; Yuki Ishizuka; Hirofumi Ohashi; Takashi Sugawara; Masaki Takahashi; Takao Noshiro; Kaoru Yoshinaga


Clinical and Experimental Hypertension | 1988

Noradrenergic Hyperactivity in Primary Hypertension; Central and Peripheral Markers of Both Behavioral Pathogenesis and Efficacy of Sympatholytic and Relaxation Therapy

Debora De-Ping Lee; Vincent DeQuattro; Gerald C. Davison; Shinobu Kimura; Robert Barndt; Patrick Sullivan


Japanese Circulation Journal-english Edition | 1985

Effects of dietary potassium on the hemodynamics and plasma norepinephrine kinetics in patients with essential hypertension.

Hirofumi Ohashi; Yukio Miura; Shinobu Kimura; Yuki Ishizuka; Takashi Sugawara; Shunichi Toriyabe; Takao Noshiro; Masaki Takahashi; Naoki Sano; Hiroshi Watanabe; Kaoru Yoshinaga


Tohoku Journal of Experimental Medicine | 1988

A Plasma Inhibitor of Sodium and Potassium Activated Adenosine Triphosphatase in Patients with Essential Hypertension

Shunichi Toriyabe; Yukio Miura; Shinobu Kimura; Yuki Meguro; Takashi Sugawara; Takao Noshiro; Masaki Takahashi; Hirofumi Ohashi; Naoki Sano; Hiroshi Watanabe; Kaoru Yoshinaga

Collaboration


Dive into the Shinobu Kimura's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge